4//SEC Filing
Stromatt Scott C 4
Accession 0001019056-18-000416
CIK 0001671584other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 7:36 PM ET
Size
7.1 KB
Accession
0001019056-18-000416
Insider Transaction Report
Form 4
Stromatt Scott C
Chief Medical Officer and SVP
Transactions
- Exercise/Conversion
Common Stock
2018-03-01+16,269→ 190,845 total - Exercise/Conversion
Restricted Stock Unit
2018-03-01−16,269→ 30,161 total→ Common Stock (16,269 underlying)
Footnotes (2)
- [F1]Each RSU converts into the Issuer's common stock on a one-for-one basis.
- [F2]The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 1, 2016. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016 (the "Spin-off"), each RSU was adjusted and assumed by the Issuer. The RSUs vest in three equal annual installments on the anniversary of the grant date.
Documents
Issuer
Aptevo Therapeutics Inc.
CIK 0001671584
Entity typeother
Related Parties
1- filerCIK 0001679975
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 7:36 PM ET
- Size
- 7.1 KB